Search Results - "Robbins, Hilary A."

Refine Results
  1. 1

    Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States by Robbins, Hilary A, Shiels, Meredith S, Pfeiffer, Ruth M, Engels, Eric A

    Published in AIDS (London) (27-03-2014)
    “…OBJECTIVE:HIV-infected people have elevated risk for some cancers. Changing incidence of these cancers over time may reflect changes in three factorsHIV…”
    Get full text
    Journal Article
  2. 2

    Excess cancers among HIV-infected people in the United States by Robbins, Hilary A, Pfeiffer, Ruth M, Shiels, Meredith S, Li, Jianmin, Hall, H Irene, Engels, Eric A

    “…Nearly 900 000 people in the United States are living with diagnosed human immunodeficiency virus (HIV) infection and therefore increased cancer risk. The…”
    Get full text
    Journal Article
  3. 3

    Sensitivity and specificity of oral HPV detection for HPV-positive head and neck cancer by Gipson, Brooke J., Robbins, Hilary A., Fakhry, Carole, D'Souza, Gypsyamber

    Published in Oral oncology (01-02-2018)
    “…•Among people with HNSCC, oral HPV detection has good specificity (92%) and moderate sensitivity (72%) for HPV-positive HNSCC.•The utility of oral HPV…”
    Get full text
    Journal Article
  4. 4

    Multicancer Early Detection Tests — Keeping a High Bar for Evidence of Benefit by Robbins, Hilary A.

    Published in The New England journal of medicine (25-07-2024)
    “…The development of multicancer early detection tests has surged in recent years. When evaluating such tests, it will be important to maintain a high bar for…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    PATHFINDER: another step on the uncharted path to multicancer screening by Lee, Richard, Robbins, Hilary A

    Published in The Lancet (British edition) (07-10-2023)
    “…Following the publication of the SYMPLIFY study,1 and in parallel to other multicancer early detection (MCED) studies, such as the NHS-Galleri randomised…”
    Get full text
    Journal Article
  10. 10

    Prevalence of and Risk Factors for Oral Human Papillomavirus Infection among HIV-Positive and HIV-Negative People Who Inject Drugs by Robbins, Hilary A, Fennell, Christina E, Gillison, Maura, Xiao, Weihong, Guo, Yingshi, Wentz, Alicia, Kirk, Gregory D, Mehta, Shruti H, D'Souza, Gypsyamber

    Published in PloS one (24-11-2015)
    “…Human papillomavirus (HPV) causes most oropharyngeal cancers in the United States. Oral HPV prevalence is associated with immunosuppression, and drug use can…”
    Get full text
    Journal Article
  11. 11

    A modeling analysis to compare eligibility strategies for lung cancer screening in Brazil by Miranda-Filho, Adalberto, Charvat, Hadrien, Bray, Freddie, Migowski, Arn, Cheung, Li C., Vaccarella, Salvatore, Johansson, Mattias, Carvalho, Andre L., Robbins, Hilary A.

    Published in EClinicalMedicine (01-12-2021)
    “…Country-specific evidence is needed to guide decisions regarding whether and how to implement lung cancer screening in different settings. For this study, we…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Age at diagnosis for lung, colon, breast and prostate cancers: An international comparative study by Zahed, Hana, Feng, Xiaoshuang, Sheikh, Mahdi, Bray, Freddie, Ferlay, Jacques, Ginsburg, Ophira, Shiels, Meredith S, Robbins, Hilary A

    Published in International journal of cancer (01-01-2024)
    “…Differences in the average age at cancer diagnosis are observed across countries. We therefore aimed to assess international variation in the median age at…”
    Get full text
    Journal Article
  16. 16

    Identification of Candidates for Longer Lung Cancer Screening Intervals Following a Negative Low-Dose Computed Tomography Result by Robbins, Hilary A, Berg, Christine D, Cheung, Li C, Chaturvedi, Anil K, Katki, Hormuzd A

    “…Lengthening the annual low-dose computed tomography (CT) screening interval for individuals at lowest risk of lung cancer could reduce harms and improve…”
    Get full text
    Journal Article
  17. 17

    Cancer Stage Compared With Mortality as End Points in Randomized Clinical Trials of Cancer Screening: A Systematic Review and Meta-Analysis by Feng, Xiaoshuang, Zahed, Hana, Onwuka, Justina, Callister, Matthew E. J, Johansson, Mattias, Etzioni, Ruth, Robbins, Hilary A

    “…IMPORTANCE: Randomized clinical trials of cancer screening typically use cancer-specific mortality as the primary end point. The incidence of stage III-IV…”
    Get full text
    Journal Article
  18. 18

    Smoking Cessation After Diagnosis of Kidney Cancer Is Associated With Reduced Risk of Mortality and Cancer Progression: A Prospective Cohort Study by Sheikh, Mahdi, Mukeriya, Anush, Zahed, Hana, Feng, Xiaoshuang, Robbins, Hilary A, Shangina, Oxana, Matveev, Vsevolod, Brennan, Paul, Zaridze, David

    Published in Journal of clinical oncology (20-05-2023)
    “…To investigate whether postdiagnosis smoking cessation may affect the risk of death and disease progression in patients with renal cell carcinoma (RCC) who…”
    Get full text
    Journal Article
  19. 19
  20. 20

    The Development and Performance of Alternative Criteria for Lung Cancer Screening by Kearney, Lauren E, Belancourt, Patrick, Katki, Hormuzd A, Tanner, Nichole T, Wiener, Renda Soylemez, Robbins, Hilary A, Landy, Rebecca, Caverly, Tanner J

    Published in Annals of internal medicine (01-09-2024)
    “…The recommendation for lung cancer screening (LCS) developed by the U.S. Preventive Services Task Force (USPSTF) may exclude some high-benefit people. To…”
    Get full text
    Journal Article